Patients/eyes (n) | 72/80 |
Sex, male (n, %) | 36 (50.0%) |
Age (year) | |
Total | 12.1 ± 3.5 |
Female | 13.3 ± 3.0 |
Male | 11.0 ± 3.6 |
Bilateral eye affected (n, %) | 8 (11.1%) |
BCVA at first visit (LogMAR) | 0.83 ± 0.51 (-0.1 ~ 2.4) |
Multimodal imaging features | |
Location of CNV (n, %) | 80 (100%) |
Subfoveal | 45 (56.25%) |
Juxtafoveal | 19 (23.75%) |
Extrafoveal | 16 (20.00%) |
FFA (n, %) | 75 (100%) |
Classic | 75 (100%) |
Occult | 0 (0%) |
ICGA (n, %) | 65 (100%) |
Focal spot | 56 (86.15%) |
Plaque | 9 (13.85%) |
OCT/OCTA (n, %) | 58 (100%) |
Type 1 | 0 (0%) |
Type 2 | 58 (100%) |
CNV activity | 80 (100%) |
Active | 46 (57.5%) |
Inactive | 34 (42.5%) |